LRMR Insider Trading - Larimar Therapeutics, Inc.

Ausstehende Aktien	103,882,937 shares
Insider-Aktien	17.751.280 shares
Insider-Besitz	17,09 %
Insider gesamt	48

Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Siehe Aktien mit dem höchsten Ranking

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Siehe Aktien mit dem höchsten Ranking

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

0 ( )

4617 out of 10916

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

0.000% ( )

4436 out of 10752

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

Larimar Therapeutics, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktien in Besitz	Split Angepasst
Patricia L Allen Chief Financial Officer - [O]	19.793	19.793
Atlas Venture Associates VII, Inc. 10% Owner - [10%]	11	11
Atlas Venture Associates VII, L.P. 10% Owner - [10%]	11	11
Atlas Venture Fund VII L P 10% Owner - [10%]	11	11
Carole Ben-maimon President and CEO, Director - [D] [O]	524.054	524.054
Peter Barrett Director, 10% Owner - [D] [10%]	4.643.327	4.643.327
Bruce Booth Director, 10% Owner - [D] [10%]	4.638.028	4.638.028
Chondrial Therapeutics Holdings, Llc 10% Owner - [10%]	8	8
Michael Celano Chief Financial Officer - [O]	215.785	215.785
Russell Clayton Chief Medical Officer - [O]	71.443	71.443
Management Co Deerfield 10% Owner - [10%]	8.300	6.207.982
Deerfield Partners, L.p. 10% Owner - [10%]	5.555.554	6.207.982
Thomas O Daniel Director - [D]	19.452	19.452
Deerfield Healthcare Innovations Fund, L.P. Director, 10% Owner - [D] [10%]	1.943.420	6.207.982
Deerfield International Master Fund, L.P. 10% Owner - [10%]	1.151.802	1.151.802
Deerfield Mgmt HIF, L.P. Director, 10% Owner - [D] [10%]	1.943.420	6.207.982

Insider	Aktien in Besitz	Split Angepasst
Deerfield Mgmt III, L.P. Director, 10% Owner - [D] [10%]	1.943.420	6.207.982
Deerfield Mgmt IV, L.P. Director, 10% Owner - [D] [10%]	1.943.420	6.207.982
Deerfield Mgmt L.P. 10% Owner - [10%]	1.151.802	6.207.982
Deerfield Private Design Fund III, L.P. Director, 10% Owner - [D] [10%]	1.943.420	6.207.982
Deerfield Private Design Fund IV, L.P. Director, 10% Owner - [D] [10%]	1.943.420	6.207.982
Deerfield Special Situations Fund, L.P. 10% Owner - [10%]	1.151.802	1.151.802
Wendy Everett	27.000
James E Flynn Director, 10% Owner - [D] [10%]	6.207.982	6.207.982
Goldberg Avi Y. Director - [D]	53.734	53.734
Thomas Edward Hamilton Director - [D]	664.798	664.798
Hatfield Jeffrey S.	525.000
Frances K Heller Director - [D]	47.961	47.961
Hughes Thomas E. See Remarks, Director - [D] [O]	125.247	125.247
Dennis D Kim Chief Medical Officer - [O]	21.443	21.443
John L Lamattina Director - [D]	31.376	31.376
Jonathan S Leff	8.300

Insider	Aktien in Besitz	Split Angepasst
Mark J Levin 10% Owner - [10%]	0	0
Patrick Loustau	56.500
Cameron Geoffrey McDonough Director - [D]	0	0
Brian McVeigh	125.000
Robert J Perez Director - [D]	5.322	5.322
Jeffrey W Sherman Director - [D]	5.000	5.000
Kevin P Starr Director - [D]	370.323	370.323
Alicia Secor Chief Commercial Officer - [O]	0	0
Gopi Shankar Chief Development Officer - [O]	76.443	76.443
Priya Singhal	375.000
Robert I Tepper 10% Owner - [10%]	0	0
Third Rock Ventures Lp 10% Owner - [10%]	0	0
Frank E Thomas Director - [D]	7.000	7.000
Trv Gp, Llc 10% Owner - [10%]	0	0
Third Rock Ventures GP, L.P. 10% Owner - [10%]	0	0
Joseph Truitt Director - [D]	2.750	2.750

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in LRMR / Larimar Therapeutics, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum	Insider	Gemeldete Aktien	Gemeldeter Preis	Angepasste Aktien	Angepasster Preis	Kostenbasis	Tage bis Max	Preis bei Max	Max Gewinn ($)	Max Rendite (%)
2026-02-27	Flynn James E	2.000.000	5,0000	2.000.000	5,0000	10.000.000	10	5.6900	1.380.000	13,80
2026-02-27	Flynn James E	831.978	5,0000	831.978	5,0000	4.159.890
2026-02-27	Flynn James E	1.084.012	5,0000	1.084.012	5,0000	5.420.060
2026-02-27	Flynn James E	1.084.010	5,0000	1.084.010	5,0000	5.420.050
2026-02-27	THOMAS FRANK E	5.000	5,0000	5.000	5,0000	25.000
2026-02-27	SHERMAN JEFFREY W	5.000	5,0000	5.000	5,0000	25.000
2026-02-27	Hamilton Thomas Edward	100.000	5,0000	100.000	5,0000	500.000
2025-07-31	Flynn James E	2.599.932	3,2000	2.599.932	3,2000	8.319.782
2025-07-31	Flynn James E	3.387.539	3,2000	3.387.539	3,2000	10.840.125

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

LRMR / Larimar Therapeutics, Inc. Insider Trades

Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in LRMR / Larimar Therapeutics, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum	Insider	Gemeldete Aktien	Gemeldeter Preis	Angepasste Aktien	Angepasster Preis	Kostenbasis	Tage bis Min
2016-07-20	Flynn James E	901.430	3,3118	901.430	3,3118	2.985.356	8
2016-07-20	Flynn James E	246.439	3,3118	246.439	3,3118	816.157
2016-07-20	Flynn James E	193.630	3,3118	193.630	3,3118	641.264
2015-09-24	STARR KEVIN P	61.630	44,1000	61.630	44,1000	2.717.883
2015-09-24	STARR KEVIN P	74.949	43,7300	74.949	43,7300	3.277.520
2015-09-17	KIM DENNIS D	9.142	40,0000	9.142	40,0000	365.680
2015-09-15	KIM DENNIS D	30.265	40,0000	30.265	40,0000	1.210.600
2015-09-14	KIM DENNIS D	593	40,0000	593	40,0000	23.720

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei Datum	Handel Datum	Form	Insider	Ticker	Wertpapier-Titel	Code	Direkt	Ausführung Preis	Einheit Preis	Eimheiten Verändert	Wert Geändert (1K)	Verbleibende Optionen	Verbleibende Aktien
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	2.000.000	10.000		6.207.982
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	831.978	4.160		8.153.107
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	1.084.012	5.420		10.622.957
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	1.084.010	5.420		10.622.928
2026-03-02	2026-02-27	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		5,0000	100.000	500		664.798
2026-03-02	2026-02-27	4	SHERMAN JEFFREY W	LRMR	Common Stock	P - Purchase	D		5,0000	5.000	25		5.000
2026-03-02	2026-02-27	4	THOMAS FRANK E	LRMR	Common Stock	P - Purchase	D		5,0000	5.000	25		7.000
2026-01-27	2026-01-26	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			100.100			368.276
2026-01-27	2026-01-26	4	Clayton Russell	LRMR	Common Stock	A - Award	D			25.637			71.443
2026-01-27	2026-01-26	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			25.637			76.443
2026-01-27	2026-01-26	4	Celano Michael	LRMR	Common Stock	A - Award	D			37.604			215.785
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		3,2000	2.599.932	8.320		7.321.129
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		3,2000	3.387.539	10.840		9.538.945
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		3,2000	3.387.529	10.840		9.538.918
2025-01-24	2025-01-22	4	Clayton Russell	LRMR	Common Stock	A - Award	D			23.306			45.806
2025-01-24	2025-01-22	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			23.306			50.806
2025-01-24	2025-01-22	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			91.000			387.208
2025-01-24	2025-01-22	4	Celano Michael	LRMR	Common Stock	A - Award	D			34.185			178.181
2024-05-31	2024-02-16	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		8,7400	57.208	500		564.798
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		8,7400	1.430.205	12.500		4.207.982
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		8,7400	1.430.206	12.500		6.151.406
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		8,7400	1.430.206	12.500		6.151.406
2024-02-15	2024-02-14	4	THOMAS FRANK E	LRMR	Common Stock	P - Purchase	D		11,0000	2.000	22		2.000
2024-01-19	2024-01-17	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			22.500			27.500
2024-01-19	2024-01-17	4	Celano Michael	LRMR	Common Stock	A - Award	D			31.250			143.996
2024-01-19	2024-01-17	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			66.125			332.954
2024-01-19	2024-01-17	4	Clayton Russell	LRMR	Common Stock	A - Award	D			22.500			22.500
2023-12-08	2023-12-07	4	Shankar Gopi	LRMR	Common Stock	P - Purchase	D		3,7323	5.000	19		5.000
2023-05-18	2023-05-17	4	BEN-MAIMON CAROLE	LRMR	Common Stock	P - Purchase	D		3,7050	5.000	19		266.829
2023-05-18	2023-05-17	4	Celano Michael	LRMR	Common Stock	P - Purchase	D		3,7263	5.000	19		112.746
2023-05-18	2023-05-17	4	Truitt Joseph	LRMR	Common Stock	P - Purchase	D		3,7300	2.750	10		2.750
2023-02-02	2023-01-31	4	Celano Michael	LRMR	Common Stock	A - Award	D			76.000			107.746
2023-02-02	2023-01-31	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			205.000			261.829
2022-09-20		3	Deerfield Mgmt L.P.	LRMR	Common Stock		D						2.777.777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2.777.777	8.750		2.777.777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2.777.777	8.750		2.777.777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2.777.777	8.750		2.777.777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2.777.777	8.750		2.777.777
2022-09-20	2022-09-16	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		3,1500	317.460	1.000		507.590
2022-09-19	2022-09-16	4	BEN-MAIMON CAROLE	LRMR	Common Stock	P - Purchase	D		3,1500	31.746	100		56.829
2022-09-19	2022-09-16	4	Celano Michael	LRMR	Common Stock	P - Purchase	D		3,1500	31.746	100		31.746
2022-05-12	2022-05-10	4	Truitt Joseph	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8.300		8.300
2022-05-12	2022-05-10	4	LEFF JONATHAN S	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8.300		8.300
2022-05-12	2022-05-10	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		20.000		20.000
2022-05-12	2022-05-10	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		40.000		40.000
2022-05-12	2022-05-10	4	THOMAS FRANK E	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8.300		8.300
2022-05-12	2022-05-10	4	Barrett Peter	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8.300		8.300
2022-05-12	2022-05-10	4	Hamilton Thomas Edward	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8.300		8.300
2022-05-11	2022-05-10	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	2,92		8.300		8.300
2022-01-20	2022-01-18	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	8,75		80.000		80.000
2022-01-20	2022-01-18	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	8,75		182.000		182.000
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		8,7500	228.570	2.000		1.943.420
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		8,7500	228.571	2.000		1.943.423
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		8,7500	228.569	2.000		1.943.406
2021-07-02	2021-06-30	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		8,7500	56.710	496		190.130
2021-05-20	2021-05-12	4	Truitt Joseph	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8.300		8.300
2021-05-17	2021-05-12	4	Hamilton Thomas Edward	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8.300		8.300
2021-05-17	2021-05-12	4	Daniel Thomas O	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8.300		8.300
2021-05-17	2021-05-12	4	THOMAS FRANK E	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8.300		8.300
2021-05-17	2021-05-12	4	Barrett Peter	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8.300		8.300
2021-05-17	2021-05-12	4	LEFF JONATHAN S	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8.300		8.300
2021-05-17	2021-05-12	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	10,34		8.300		8.300
2021-01-21	2021-01-19	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	19,61		106.700		106.700
2021-01-21	2021-01-19	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	19,61		42.000		42.000
2020-10-01	2020-09-29	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	11,90		16.600		16.600
2020-09-30	2020-09-29	4	Hamilton Thomas Edward	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16.600		16.600
2020-09-30	2020-09-29	4	Daniel Thomas O	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16.600		16.600
2020-09-30	2020-09-29	4	Barrett Peter	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16.600		16.600
2020-09-30	2020-09-29	4	Celano Michael	LRMR	Stock Option (right to buy)	A - Award	D	11,90		84.100		84.100
2020-09-30	2020-09-29	4	Truitt Joseph	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16.600		16.600
2020-09-30	2020-09-29	4	LEFF JONATHAN S	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16.600		16.600
2020-09-30	2020-09-29	4	THOMAS FRANK E	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16.600		16.600
2020-09-30	2020-09-29	4	BEN-MAIMON CAROLE	LRMR	Stock Option (right to buy)	A - Award	D	11,90		411.400		411.400
2020-06-30	2020-06-26	4	BEN-MAIMON CAROLE	LRMR	Common Stock	J - Other	D			25.083			25.083
2020-06-30	2020-06-26	4	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock	J - Other	D			-6.091.242			8
2020-06-30	2020-06-26	4	Hamilton Thomas Edward FA Life Sciences, Inc.	LRMR	Common Stock	J - Other	I			159.433			292.853
2020-06-30	2020-06-26	4	Hamilton Thomas Edward	LRMR	Common Stock	J - Other	D			133.420			133.420
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12.182.500
2020-06-05	2020-05-28	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	11,88		60.479		60.479
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12.182.500
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12.182.500
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12.182.500
2019-06-27	2019-06-26	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-06-27	2019-06-26	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-06-27	2019-06-26	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-06-27	2019-06-26	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-06-27	2019-06-26	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-06-27	2019-06-26	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-06-27	2019-06-26	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27.000		27.000
2019-04-04	2019-04-02	4	Singhal Priya	ZFGN	Stock Option (Right to Buy)	A - Award	D	2,89		375.000		375.000
2019-01-28	2019-01-24	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		21.396		21.396
2019-01-28	2019-01-24	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		11.804		11.804
2019-01-28	2019-01-24	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		13.280		13.280
2019-01-28	2019-01-24	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		5.717		5.717
2019-01-28	2019-01-24	4	PEREZ ROBERT J	ZFGN	Common Stock	A - Award	D		4,3800	4.423	19		5.322
2019-01-28	2019-01-24	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		4,3800	10.844	47		31.376
2019-01-24	2019-01-22	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		125.000		125.000
2019-01-24	2019-01-22	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		95.000		95.000
2019-01-24	2019-01-22	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		525.000		525.000
2019-01-24	2019-01-22	4	McVeigh Brian	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		125.000		125.000
2018-07-02	2018-06-29	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-234.321			11
2018-07-02	2018-06-29	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-1.126.546			3.506.184
2018-06-29	2018-06-28	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		10,0000	-32.000	-320		125.247
2018-06-07	2018-06-06	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-06-07	2018-06-06	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-06-07	2018-06-06	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-06-07	2018-06-06	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-06-07	2018-06-06	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-06-07	2018-06-06	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-06-07	2018-06-06	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		40.000		40.000
2018-06-07	2018-06-06	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20.000		20.000
2018-05-30	2018-05-29	4	McVeigh Brian	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,46		225.000		225.000
2018-03-09	2018-03-07	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		10,0000	-5.000	-50		157.247
2018-02-23	2018-02-22	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,77		125.000		125.000
2018-02-23	2018-02-22	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,77		275.000		275.000
2018-02-23	2018-02-22	4	Hughes Thomas E.	ZFGN	Stock Option (right to buy)	A - Award	D	7,77		275.000		275.000
2018-02-23	2018-02-22	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,77		125.000		125.000
2018-01-05	2018-01-03	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		9.421		9.421
2018-01-05	2018-01-03	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		9.725		9.725
2018-01-05	2018-01-03	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		8.509		8.509
2018-01-05	2018-01-03	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		17.627		17.627
2018-01-05	2018-01-03	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		5,1800	9.169	47		20.532
2018-01-05	2018-01-03	4	Daniel Thomas O	ZFGN	Common Stock	A - Award	D		5,1800	8.687	45		19.452
2017-12-29	2017-12-29	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,40		1.100.000		1.100.000
2017-10-17	2017-10-13	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3,8988	10.000	39		47.961
2017-10-11	2017-10-09	4	Hughes Thomas E.	ZFGN	Employee Stock Option (right to buy)	A - Award	D	3,40		275.000		275.000
2017-10-11	2017-10-09	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,40		550.000		550.000
2017-07-12	2017-07-11	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		3,3900	10.000	34		21.443
2017-06-23	2017-06-21	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-06-23	2017-06-21	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14.500		14.500
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,82		-68.073		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		-6.210		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy	M - Exercise	D	0,75		-18.928		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,8200	68.073	56		157.371
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	6.210	5		89.298
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	18.928	14		83.088
2017-05-11	2017-05-11	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		4,4000	9.800	43		11.443
2017-05-11	2017-05-10	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		4,4000	200	1		1.643
2017-02-14	2017-02-13	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		12.003		12.003
2017-02-14	2017-02-13	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		13.718		13.718
2017-02-14	2017-02-13	4	Daniel Thomas O	ZFGN	Common Stock	A - Award	D		4,1800	10.765	45		10.765
2017-02-14	2017-02-13	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		13.289		13.289
2017-02-14	2017-02-13	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		4,1800	11.363	47		11.363
2017-02-14	2017-02-13	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		24.864		24.864
2017-01-31	2017-01-27	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,05		88.000		88.000
2017-01-31	2017-01-27	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,05		88.000		88.000
2017-01-31	2017-01-27	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,05		319.000		319.000
2016-12-20	2016-12-19	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3,2290	10.000	32		30.000
2016-11-17	2016-11-15	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3,5434	10.000	35		20.000
2016-08-31	2016-08-29	4	Hughes Thomas E.	ZFGN	Common Stock	P - Purchase	D		2,9987	10.000	30		63.936
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	S - Sale	I		3,3118	-901.430	-2.985		1.151.802
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	S - Sale	I		3,3118	-246.439	-816		314.889
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	S - Sale	I		3,3118	-193.630	-641		247.413
2016-07-26	2016-07-26	4	Allen Patricia L	ZFGN	Common Stock	P - Purchase	D		3,1500	8.200	26		19.793
2016-07-26	2016-07-25	4	Allen Patricia L	ZFGN	Common Stock	P - Purchase	D		3,0810	7.800	24		11.593
2016-07-26	2016-07-22	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		2,9900	10.000	30		10.000
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		25.000		18.928
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Common Stock	P - Purchase	D		3,0208	5.000	15		53.936
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	25.000	19		48.936
2016-07-01	2016-06-30	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-07-01	2016-06-30	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12.000		12.000
2016-04-12	2016-01-07	4	PEREZ ROBERT J See note	ZFGN	Common Stock	A - Award	I		6,2900	5.564	35		5.564
2016-04-04	2016-03-31	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		36.000		36.000
2016-04-04	2016-03-31	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		72.000		72.000
2016-04-04	2016-03-31	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		37.500		37.500
2016-04-04	2016-03-31	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		75.000		75.000
2016-04-04	2016-04-01	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,70		3.841		3.841
2016-04-04	2016-04-01	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,70		24.000		24.000
2016-04-04	2016-04-01	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,91		6.100		6.100
2016-04-04	2016-04-01	4	McDonough Cameron Geoffrey	ZFGN	Common Stock	D - Sale to Issuer	D		7,9100	-4.424	-35		0
2016-04-04	2016-03-31	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		-26.500		26.500
2016-04-04	2016-03-31	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		-53.000		53.000
2016-04-04	2016-03-31	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		56.500		56.500
2016-04-04	2016-03-31	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		113.000		113.000
2016-04-04	2016-03-31	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		124.500		124.500
2016-04-04	2016-03-31	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		249.000		249.000
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2466	13.872	87		2.053.232
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2466	28.377	177		561.328
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2466	22.296	139		441.043
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3.049.910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4.705.436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3.138.914
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,1884	504	3		2.039.360
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,1884	1.030	6		532.951
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6,1884	810	5		418.747
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2323	32.501	203		2.038.856
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2323	66.486	414		531.921
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2323	52.239	326		417.937
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		5,7291	24.484	140		2.006.355
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		5,7291	50.086	287		465.435
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		5,7291	39.353	225		365.698
2016-01-27	2016-01-25	4	Barrett Peter	ZFGN	Common Stock	A - Award	D		7,9100	8.849	70		4.643.327
2016-01-27	2016-01-25	4	McDonough Cameron Geoffrey	ZFGN	Common Stock	A - Award	D		7,9100	4.424	35		4.424
2016-01-27	2016-01-25	4	Booth Bruce	ZFGN	Common Stock	A - Award	D		7,9100	4.424	35		4.638.028
2016-01-27	2016-01-25	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,91		9.150		9.150
2016-01-08	2016-01-08	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		-10.000		43.928
2016-01-08	2016-01-08	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	10.000	8		21.320
2015-10-30	2015-10-28	4	PEREZ ROBERT J	ZFGN	Common Stock	A - Award	D		10,4500	899	9		899
2015-10-30	2015-10-28	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	10,45		1.207		1.207
2015-10-20	2015-09-14	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-593	-24		0
2015-10-20	2015-09-17	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-9.142	-366		0
2015-10-20	2015-09-15	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-30.265	-1.211		0
2015-09-28	2015-09-24	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	40,56		24.000		24.000
2015-09-28	2015-09-24	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	40,56		24.000		24.000
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			98.834			370.323
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-476.170			0
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			476.170			476.170
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	S - Sale	I		44,1000	-61.630	-2.718		210.371
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	S - Sale	I		43,7300	-74.949	-3.278		272.001
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1.655.095			346.950
2015-09-24	2015-09-23	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		-10.500		53.928
2015-09-24	2015-09-23	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	10.500	8		11.320
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	2,45		-23.126		160.555
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		45,0000	-23.126	-1.041		820
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		2,4500	23.126	57		23.946
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	2,45		-4.874		183.681
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		40,0000	-22.500	-900		820
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		2,4500	4.874	12		23.320
2015-09-21	2015-09-18	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		45,0000	-5.000	-225		53.734
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	9,67		-25.000		134.235
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	S - Sale	D		41,0500	-1.256	-52		0
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	S - Sale	D		41,0500	-25.000	-1.026		1.256
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	M - Exercise	D		9,6700	25.000	242		26.256
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1,57		-9.142		103.312
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-9.142	-366		0
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1,5700	9.142	14		9.142
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1,57		-30.265		112.454
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-30.265	-1.211		0
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1,5700	30.265	48		30.265
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1,57		-593		142.719
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-593	-24		0
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1,5700	593	1		593
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			99.351			271.489
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-479.081			0
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			479.081			479.081
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1.200.000			2.002.045
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-479.081			0
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			479.081			479.081
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1.200.000			2.002.045
2015-07-15	2015-07-13	4	STARR KEVIN P	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-07-15	2015-07-13	4	Goldberg Avi Y.	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-07-15	2015-07-13	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-07-15	2015-07-13	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-07-15	2015-07-13	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-07-15	2015-07-13	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-07-15	2015-07-13	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12.000		12.000
2015-06-12	2015-06-10	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		35,0000	-3.000	-105		58.734
2015-06-03	2015-06-01	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		32,2262	-2.000	-64		61.734
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			92.041			172.138
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-443.935			0
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			443.935			443.935
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1.000.000			3.202.045
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-443.935			0
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			443.935			443.935
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1.000.000			3.202.045
2015-03-26	2015-03-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-1.000.000			4.632.730
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			71.989			80.097
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-346.658			0
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			346.658			346.658
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1.400.000			4.202.045
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-346.658			0
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			346.658			346.658
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1.400.000			4.202.045
2015-03-19	2015-03-17	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	45,57		180.000		180.000
2015-03-03	2015-02-27	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		60.000		187.388
2015-03-03	2015-02-27	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		90.000		281.509
2015-03-03	2015-02-27	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		60.000		219.235
2015-03-03	2015-02-27	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		45.000		324.777
2015-01-12	2015-01-08	4	Booth Bruce	ZFGN	Common Stock	A - Award	D		40,0400	874	35		5.633.604
2015-01-12	2015-01-08	4	STARR KEVIN P	ZFGN	Common Stock	A - Award	D		40,0400	1.248	50		9.356
2015-01-12	2015-01-08	4	Barrett Peter	ZFGN	Common Stock	A - Award	D		40,0400	1.748	70		5.634.478
2015-01-12	2015-01-08	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	40,04		1.593		9.554
2014-11-03	2014-10-30	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	21,34		13.327		13.327
2014-06-26	2014-06-24	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	16,00		13.327		13.327
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series D Preferred Stock	C - Conversion	I			-4.666.478		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series C Preferred Stock	C - Conversion	I			-8.263.595		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series B Preferred Stock	C - Conversion	I			-22.250.770		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			743.070			5.610.153
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			1.315.859			4.867.083
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			3.543.116			3.551.224
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series D Preferred Stock	C - Conversion	I			-4.690.696		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series C Preferred Stock	C - Conversion	I			-8.263.595		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series B Preferred Stock	C - Conversion	I			-17.651.253		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series A Preferred Stock	C - Conversion	I			-4.768.001		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			746.926			5.632.730
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			1.315.859			4.885.804
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			2.810.709			3.569.945
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			759.236			759.236
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series D Preferred Stock	C - Conversion	D			-4.690.696		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series C Preferred Stock	C - Conversion	D			-8.263.595		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series B Preferred Stock	C - Conversion	D			-17.651.253		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series A Preferred Stock	C - Conversion	D			-4.768.001		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			746.926			5.632.730
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			1.315.859			4.885.804
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			2.810.709			3.569.945
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			759.236			759.236
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series D Preferred Stock	C - Conversion	I			-4.690.696		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series C Preferred Stock	C - Conversion	I			-8.263.595		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series B Preferred Stock	C - Conversion	I			-17.651.253		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series A Preferred Stock	C - Conversion	I			-4.768.001		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			746.926			5.632.730
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			1.315.859			4.885.804
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			2.810.709			3.569.945
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			759.236			759.236
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series D Preferred Stock	C - Conversion	D			-4.666.478		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series C Preferred Stock	C - Conversion	D			-8.263.595		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series B Preferred Stock	C - Conversion	D			-22.250.770		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			743.070			5.602.045
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			1.315.859			4.858.975
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			3.543.116			3.543.116
2014-06-26	2014-06-24	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	16,00		279.777		279.777
2014-06-23	2014-06-19	4	Secor Alicia Held by Spouse	ZFGN	Common Stock	P - Purchase	I		20,0000	4.000	80		4.000
2014-06-18		3	STARR KEVIN P	ZFGN	Common Stock		D						16.216
2014-06-18		3	STARR KEVIN P	ZFGN	Common Stock		D						16.216
2014-06-18		3	Hughes Thomas E.	ZFGN	Common Stock		D						70.506
2014-06-18		3	Hughes Thomas E.	ZFGN	Common Stock		D						70.506
2014-06-18		3	Goldberg Avi Y.	ZFGN	Common Stock		I						695.284
2014-06-18		3	Goldberg Avi Y.	ZFGN	Common Stock		I						695.284

Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren

Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren

Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)

Umwandlung von Derivaten

Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen

Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere

Schenkung von Wertpapieren durch oder an den Insider

Aktien-Swaps und ähnliche Absicherungstransaktionen

Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)

Eine freiwillig auf Formular 4 gemeldete Transaktion

Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)

LRMR / Larimar Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5